164 related articles for article (PubMed ID: 29615404)
1. The tumor suppressive TGF-β/SMAD1/S1PR2 signaling axis is recurrently inactivated in diffuse large B-cell lymphoma.
Stelling A; Hashwah H; Bertram K; Manz MG; Tzankov A; Müller A
Blood; 2018 May; 131(20):2235-2246. PubMed ID: 29615404
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological DNA demethylation restores SMAD1 expression and tumor suppressive signaling in diffuse large B-cell lymphoma.
Stelling A; Wu CT; Bertram K; Hashwah H; Theocharides APA; Manz MG; Tzankov A; Müller A
Blood Adv; 2019 Oct; 3(20):3020-3032. PubMed ID: 31648327
[TBL] [Abstract][Full Text] [Related]
3. The hematopoietic oncoprotein FOXP1 promotes tumor cell survival in diffuse large B-cell lymphoma by repressing S1PR2 signaling.
Flori M; Schmid CA; Sumrall ET; Tzankov A; Law CW; Robinson MD; Müller A
Blood; 2016 Mar; 127(11):1438-48. PubMed ID: 26729899
[TBL] [Abstract][Full Text] [Related]
4. Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma.
Muppidi JR; Schmitz R; Green JA; Xiao W; Larsen AB; Braun SE; An J; Xu Y; Rosenwald A; Ott G; Gascoyne RD; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Vaidehi N; Staudt LM; Cyster JG
Nature; 2014 Dec; 516(7530):254-8. PubMed ID: 25274307
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of CREBBP expands the germinal center B cell compartment, down-regulates MHCII expression and promotes DLBCL growth.
Hashwah H; Schmid CA; Kasser S; Bertram K; Stelling A; Manz MG; Müller A
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9701-9706. PubMed ID: 28831000
[TBL] [Abstract][Full Text] [Related]
6. Regulation of S1PR2 by the EBV oncogene LMP1 in aggressive ABC-subtype diffuse large B-cell lymphoma.
Vockerodt M; Vrzalikova K; Ibrahim M; Nagy E; Margielewska S; Hollows R; Lupino L; Tooze R; Care M; Simmons W; Schrader A; Perry T; Abdullah M; Foster S; Reynolds G; Dowell A; Rudzki Z; Krappmann D; Kube D; Woodman C; Wei W; Taylor G; Murray PG
J Pathol; 2019 Jun; 248(2):142-154. PubMed ID: 30666658
[TBL] [Abstract][Full Text] [Related]
7. S1PR2 deficiency in DLBCL: a FOXy connection.
Baldari CT
Blood; 2016 Mar; 127(11):1380-1. PubMed ID: 26989186
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-phosphate/S1PR2-mediated signaling triggers Smad1/5/8 phosphorylation and thereby induces Runx2 expression in osteoblasts.
Higashi K; Matsuzaki E; Hashimoto Y; Takahashi-Yanaga F; Takano A; Anan H; Hirata M; Nishimura F
Bone; 2016 Dec; 93():1-11. PubMed ID: 27612439
[TBL] [Abstract][Full Text] [Related]
9. TGF-β-induced growth inhibition in B-cell lymphoma correlates with Smad1/5 signalling and constitutively active p38 MAPK.
Bakkebø M; Huse K; Hilden VI; Smeland EB; Oksvold MP
BMC Immunol; 2010 Nov; 11():57. PubMed ID: 21092277
[TBL] [Abstract][Full Text] [Related]
10. The Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor 2 Axis in Intestinal Epithelial Cells Regulates Intestinal Barrier Function During Intestinal Epithelial Cells-CD4+T-Cell Interactions.
Chen T; Lin R; Jin S; Chen R; Xue H; Ye H; Huang Z
Cell Physiol Biochem; 2018; 48(3):1188-1200. PubMed ID: 30045015
[TBL] [Abstract][Full Text] [Related]
11. Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation.
Singh RR; Kim JE; Davuluri Y; Drakos E; Cho-Vega JH; Amin HM; Vega F
Leukemia; 2010 May; 24(5):1025-36. PubMed ID: 20200556
[TBL] [Abstract][Full Text] [Related]
12. S1PR2 links germinal center confinement and growth regulation.
Green JA; Cyster JG
Immunol Rev; 2012 May; 247(1):36-51. PubMed ID: 22500830
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-β stimulates Smad1/5 signaling in pulmonary artery smooth muscle cells and fibroblasts of the newborn mouse through ALK1.
Zhang H; Du L; Zhong Y; Flanders KC; Roberts JD
Am J Physiol Lung Cell Mol Physiol; 2017 Sep; 313(3):L615-L627. PubMed ID: 28642261
[TBL] [Abstract][Full Text] [Related]
14. TGFbeta-mediated activation of Smad1 in B-cell non-Hodgkin's lymphoma and effect on cell proliferation.
Munoz O; Fend F; de Beaumont R; Husson H; Astier A; Freedman AS
Leukemia; 2004 Dec; 18(12):2015-25. PubMed ID: 15470494
[TBL] [Abstract][Full Text] [Related]
15. JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide.
Xu PP; Sun YF; Fang Y; Song Q; Yan ZX; Chen Y; Jiang XF; Fei XC; Zhao Y; Leboeuf C; Li B; Wang CF; Janin A; Wang L; Zhao WL
Sci Rep; 2017 Aug; 7(1):7433. PubMed ID: 28785100
[TBL] [Abstract][Full Text] [Related]
16. Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation.
Cattoretti G; Mandelbaum J; Lee N; Chaves AH; Mahler AM; Chadburn A; Dalla-Favera R; Pasqualucci L; MacLennan AJ
Cancer Res; 2009 Nov; 69(22):8686-92. PubMed ID: 19903857
[TBL] [Abstract][Full Text] [Related]
17. S1PR1 is an effective target to block STAT3 signaling in activated B cell-like diffuse large B-cell lymphoma.
Liu Y; Deng J; Wang L; Lee H; Armstrong B; Scuto A; Kowolik C; Weiss LM; Forman S; Yu H
Blood; 2012 Aug; 120(7):1458-65. PubMed ID: 22745305
[TBL] [Abstract][Full Text] [Related]
18. Smurf2 suppresses B-cell proliferation and lymphomagenesis by mediating ubiquitination and degradation of YY1.
Ramkumar C; Cui H; Kong Y; Jones SN; Gerstein RM; Zhang H
Nat Commun; 2013; 4():2598. PubMed ID: 24121673
[TBL] [Abstract][Full Text] [Related]
19. UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma.
Bedekovics T; Hussain S; Feldman AL; Galardy PJ
Blood; 2016 Mar; 127(12):1564-74. PubMed ID: 26702068
[TBL] [Abstract][Full Text] [Related]
20. The tumor suppressive role of inhibin βA in diffuse large B-cell lymphoma.
Jiang L; Si T; Yu M; Zeng X; Morse HC; Lu Y; Ouyang G; Zhou JX
Leuk Lymphoma; 2018 May; 59(5):1202-1212. PubMed ID: 28877610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]